State of Wyoming’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

State of Wyoming’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,236	Closed	-$5K	–	2126
2021 Q4	$5K	Buy	2,236 +138	+7%	+$562	﹤0.01%	1729
2021 Q3	$11K	Sell	2,098 -14	-0.7%	-$87	0.01%	1022
2021 Q2	$16K	Buy	+2,112	New	+$15K	0.01%	966

Other funds holding KLDO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wyoming's KLDO Position: Q1 2022 in Review

State of Wyoming sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q1 2022, closing a stake of 2,236 shares — an estimated $5K sold.

State of Wyoming first reported a position in KLDO in Q2 2021 and held it in 3 quarters. The position peaked at $16K in Q2 2021. 63 funds tracked by Wall St. Rank hold KLDO as of Q1 2022.

State of Wyoming reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
State of Wyoming sold 2,236 Kaleido Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $5K.
State of Wyoming first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
State of Wyoming's Kaleido Biosciences, Inc. Common Stock position peaked at $16K in Q2 2021.
63 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2022.

Based on State of Wyoming's 13F filing for Q1 2022, filed 13 May 2022.